Skip to content
Rare Medication

Shortage status

Lidocaine shortage - supply and sourcing support

Yes.

Lidocaine is on the FDA drug shortage list.

FDA status
Current
Reported availability
Available
Affected form
Injection
FDA updated
09/15/2026

Presentations listed by the FDA

62 in total

Source: FDA drug shortage database - checked 20 Sept 2026 - open the FDA record

A shortage rarely means a medicine has vanished. Usually one presentation is short while others keep shipping, and how long it lasts depends on why it started. Below is what is known about Lidocaine supply right now, what tends to be affected, and what you can do about it today. A medicine can be short nationally and still sit on a shelf near you, or the reverse. National lists tell you the direction of travel, your pharmacy tells you what is in the drawer today.

What to do now

  1. 1Ask your pharmacy about other strengths, pack sizes and manufacturers. A shortage usually hits one presentation, not all of them.
  2. 2Ask your prescriber whether an alternative is suitable. Never change dose, brand or schedule on your own.
  3. 3If nothing works locally, tell us the exact presentation and we will check licensed suppliers.
Ask us to find it

What usually goes short, and what does not

Shortages hit a presentation, not an ingredient: one strength, one pack size, or one manufacturer's line. A different strength of the same medicine, or the same strength from another maker, is often still available, which is why the first question to a pharmacy is not «do you have it» but «which of these do you have».

Teams revisit Lidocaine when wholesaler tiers signal constraints, when clinical programs require a specific presentation, or when regional registration limits usual channels.

We do not guarantee supply. Any follow-up is subject to product eligibility, licensing, and market conditions.

Market signals and documentation

Confirm the International Nonproprietary Name (INN) for your request: Lidocaine. Trade names and pack sizes vary by market.

Therapeutic context often referenced in procurement for this entry: Hospital medicines. This does not replace clinical protocols.

For quotation review, teams typically prepare: strength, dosage form, pack size, destination country, and organization billing or licensing identifiers as required by your process.

Availability may depend on jurisdiction and regulatory status. Your compliance team should validate import and dispensing requirements.

Trust: compliant shortage support

Shortage pressure should not push buyers toward informal channels. Rare Medication focuses on compliant sourcing support for eligible organizations - not informal sellers or unverified brokers.

  • Reviews are handled with procurement and compliance framing in mind, including destination country and product authorization context.
  • Procurement questions related to Lidocaine are reviewed in line with authorized wholesale norms and destination-country rules.
  • We do not facilitate unlicensed sales, personal import for resale, or circumvention of prescribing rules.
  • If follow-up is possible, it should stay within authorized wholesale and documentation norms for your jurisdiction.

Request availability for your organization

Next step: Submit a procurement inquiry for licensed-organization review. Include organization context so reviewers can assess feasibility responsibly. No payment or purchase obligation at submission.

Why teams use structured shortage inquiries

When usual channels are constrained, a clear procurement request helps reviewers assess feasibility without bypassing law or institutional controls.

  • Licensed healthcare organizations and professional procurement contacts only
  • Quotation-based review - no obligation and no guaranteed allocation
  • Documentation expectations explained during follow-up where applicable
  • Aligned with distributor advisories and your local compliance rules

Frequently asked questions